← The FDA Ephemeris: the whole map
Leqembi lecanemab-irmb
Queued: 28 FDA documents (1,413 pages) are in the system, waiting to be read into the graph.
- Application
- BLA 761269
- Sponsor
- Eisai
- Drug class
- Anti-amyloid antibody
- First approved
- January 6, 2023
FDA decisions
Also anti-amyloid antibodys: Aduhelm, Kisunla, Leqembi Iqlik
From FDA documents. Not medical advice.